Cite
MLA Citation
Donggeon Kim et al.. “572 Fibroblast activating protein (FAP)-targeting IL-12 (anti-FAP/IL-12) TMEkine™ potentiates anti-cancer effects in preclinical cancer models.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A344. http://access.bl.uk/ark:/81055/vdc_100144724019.0x000003